Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Cardiovascular disease is a term used to describe diseases of the heart and blood vessels. Some of the common types of cardiovascular disease include coronary artery disease, heart attack, and heart ...

The festive season is here, so you know what that means: it's party time! We've got just what you need to start up the conversation and get everyone in the mood. Whether you're playing Never Have I ...